PubMed=9437822; DOI=10.1016/S0165-2427(97)00053-6
Momoi Y., Okai Y., Watari T., Goitsuka R., Tsujimoto H., Hasegawa A.
Establishment and characterization of a canine T-lymphoblastoid cell line derived from malignant lymphoma.
Vet. Immunol. Immunopathol. 59:11-20(1997)

PubMed=22236332; DOI=10.1111/j.1476-5829.2011.00299.x
Seiser E.L., Thomas R., Richards K.L., Kelley M.K., Moore P., Suter S.E., Breen M.
Reading between the lines: molecular characterization of five widely used canine lymphoid tumour cell lines.
Vet. Comp. Oncol. 11:30-50(2013)

PubMed=23365669; DOI=10.1371/journal.pone.0054464; PMCID=PMC3554772
Wells J.W., Evans C.H., Scott M.C., Rutgen B.C., O'Brien T.D., Modiano J.F., Cvetkovic G., Tepic S.
Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation.
PLoS ONE 8:e54464.1-e54464.9(2013)

PubMed=29674676; DOI=10.1038/s41598-018-23207-7; PMCID=PMC5908872
Taher L., Beck J., Liu W., Roolf C., Soller J.T., Rutgen B.C., Hammer S.E., Chodisetti M., Sender S., Sterenczak K.A., Fuellen G., Junghanss C., Brenig B., Nolte I., Schutz E., Murua Escobar H.
Comparative high-resolution transcriptome sequencing of lymphoma cell lines and de novo lymphomas reveals cell-line-specific pathway dysregulation.
Sci. Rep. 8:6279-6279(2018)